Proteomic analysis reveals co-ordinated alterations in protein synthesis and degradation pathways in LRRK2 knockout mice. (18th June 2018)

• Record Type: Journal Article
• Authors: Pellegrini, Laura; Hauser, David N; Li, Yan; Mamais, Adamantios; Beilina, Alexandra; Kumaran, Ravindran; Wetzel, Andrea; Nixon-Abell, Jonathon; Heaton, George; Rudenko, Iakov; Alkaslasi, Mor; Ivanina, Natalie; Melrose, Heather L; Cookson, Mark R; Harvey, Kirsten
• Is Part Of: Human molecular genetics. Volume 27:Number 18(2018:Sep. 15)
• Page Start: 3257
• Page End: 3271
• Publication Date: 2018-06-18
• Subjects: Human molecular genetics -- Periodicals; Human chromosome abnormalities -- Periodicals; 572.8
• DOI: 10.1093/hmg/ddy232
• Languages: English
• ISSNs: 0964-6906

Abstract

Abstract: Mutations in leucine-rich repeat kinase 2 ( LRRK2 ) segregate with familial Parkinson's disease (PD) and genetic variation around LRRK2 contributes to risk of sporadic disease. Although knockout (KO) of Lrrk2 or knock-in of pathogenic mutations into the mouse germline does not result in a PD phenotype, several defects have been reported in the kidneys of Lrrk2 KO mice. To understand LRRK2 function in vivo, we used an unbiased approach to determine which protein pathways are affected in LRRK2 KO kidneys. We nominated changes in cytoskeletal-associated proteins, lysosomal proteases, proteins involved in vesicular trafficking and in control of protein translation. Changes were not seen in mice expressing the pathogenic G2019S LRRK2 mutation. Using cultured epithelial kidney cells, we replicated the accumulation of lysosomal proteases and demonstrated changes in subcellular distribution of the cation-independent mannose-6-phosphate receptor. These results show that loss of LRRK2 leads to co-ordinated responses in protein translation and trafficking and argue against a dominant negative role for the G2019S mutation.